Osteopontin and Angiogenic Factors as New Biomarkers of Prostate Cancer

被引:1
|
作者
Wisniewski, Tomasz [1 ,2 ]
Zyromska, Agnieszka [1 ,3 ]
Makarewicz, Roman [1 ]
Zekanowska, Ewa [4 ]
机构
[1] Nicolaus Copernicus Univ, Coll Med, Dept Oncol & Brachytherapy, Ul Dr I Romanowskiej 2, PL-85796 Bydgoszcz, Poland
[2] Franciszek Lukaszczyk Oncol Ctr, Radiotherapy Dept, Bydgoszcz, Poland
[3] Amethyst Radiotherapy Ctr, Zgorzelec, Poland
[4] Nicolaus Copernicus Univ, Dept Pathophysiol, Coll Med, Bydgoszcz, Poland
关键词
osteopontin; angiogenesis factors; prostate cancer; ENDOTHELIAL GROWTH-FACTOR; ANGIOSTATIN-LIKE FRAGMENTS; PLASMA OSTEOPONTIN; NECK-CANCER; ADVANCED HEAD; HYPOXIA; RADIOTHERAPY; EXPRESSION; THROMBOSPONDIN-1; MARKERS;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The novel biomarkers that would identify patients at risk for relapse and metastatic spread are needed. The aim of this study was the evaluation of serum levels of osteopontin (OPN) and tumor endogenous angiogenic factors such as vascular endothelial growth factor (VEGF), vascular-endothelial growth factor receptor 2 (VEGF R2), endostatin, angiostatin and thrombospondin 1, in prostate cancer (PC) patients. Material and Methods: Blood concentrations of the analyzed parameters were determined in 40 prostate cancer patients eligible for radiotherapy as well as in a control group consisting of 25 volunteers. Commercial ELISA kits were used for the analysis. Results: Significantly higher levels of OPN (101.49 ng/mL vs 59.88 ng/mL; P < .001), endostatin (252.60 ng/mL vs. 223.55 ng/mL; P = .043), angiostatin (47 ng/mL vs. 13 ng/mL; P = .047), VEGF (262.1 pg/mL vs. 138.0 pg/mL; P = .056) and VEGF R2 (11188.81 pg/mL vs. 9377.50 pg/mL; P = .047) were detected in PC patients compared with the control group. In PC patients we showed a positive correlation between OPN level and TNM clinical stage (R = 0.36; P = .02) and negative correlation between OPN level and hemoglobin concentration (R=-0.33; P = .04). Conclusion: The study showed higher levels of the angiogenic factors in PC patients compared with the control group and identified OPN as an indicator of the PC clinical stage as well as a decreased hemoglobin level.
引用
收藏
页码:134 / 140
页数:7
相关论文
共 50 条
  • [41] Osteopontin is a tumor autoantigen in prostate cancer patients
    Tilli, Tatiana M.
    Silva, Eloisio A.
    Matos, Livia C.
    Faget, Douglas V.
    Dias, Bianca F. P.
    Vasconcelos, Juliana S. P.
    Yokosaki, Yasuyuki
    Gimba, Etel R. P.
    [J]. ONCOLOGY LETTERS, 2011, 2 (01) : 109 - 114
  • [42] Osteopontin: Possible role in prostate cancer progression
    Thalmann, GN
    Sikes, RA
    Devoll, RE
    Kiefer, JA
    Markwalder, R
    Klima, I
    Farach-Carson, CM
    Studer, UE
    Chung, LWK
    [J]. CLINICAL CANCER RESEARCH, 1999, 5 (08) : 2271 - 2277
  • [43] Biomarkers for Anti-Angiogenic Therapy in Cancer
    Wehland, Markus
    Bauer, Johann
    Magnusson, Nils E.
    Infanger, Manfred
    Grimm, Daniela
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (05) : 9338 - 9364
  • [44] Angiogenic factors and bladder cancer
    Shao, ZM
    Nguyen, M
    [J]. FRONTIERS IN BIOSCIENCE, 2002, 7 : E33 - E35
  • [45] Angiogenic factors in breast cancer
    Yasasever, V.
    Soyclinc, H. Oguz
    Camlica, H.
    Duranyildiz, D.
    Dalay, N.
    [J]. EJC SUPPLEMENTS, 2008, 6 (09): : 131 - 131
  • [46] Angiogenic factors as biomarkers for fetal wellbeing during delivery
    Sterpu, Irene S.
    Akerud, Helena
    Kaihola, Helena
    Itzel, Eva Wiberg
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 218 (01) : S186 - S186
  • [47] EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis
    Li, Lechen
    Ameri, Amir H.
    Wang, Simeng
    Jansson, Keith H.
    Casey, Orla M.
    Yang, Qi
    Beshiri, Michael L.
    Fang, Lei
    Lake, Ross G.
    Agarwal, Supreet
    Alilin, Aian N.
    Xu, Wanhai
    Yin, JuanJuan
    Kelly, Kathleen
    [J]. ONCOGENE, 2019, 38 (35) : 6241 - 6255
  • [48] New Biomarkers and Application of Multivariate Models for Detection of Prostate Cancer
    Stephan, C.
    Cammann, H.
    Rittenhouse, H.
    Lein, M.
    Jentzmik, F.
    Schrader, M.
    Deger, S.
    Miller, K.
    Jung, K.
    [J]. AKTUELLE UROLOGIE, 2009, 40 (04) : 221 - 230
  • [49] The Impact of Lifestyle on Prostate Cancer: A Road to the Discovery of New Biomarkers
    Leitao, Catarina
    Matos, Barbara
    Roque, Fatima
    Herdeiro, Maria Teresa
    Fardilha, Margarida
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (10)
  • [50] EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis
    Lechen Li
    Amir H. Ameri
    Simeng Wang
    Keith H. Jansson
    Orla M. Casey
    Qi Yang
    Michael L. Beshiri
    Lei Fang
    Ross G. Lake
    Supreet Agarwal
    Aian N. Alilin
    Wanhai Xu
    JuanJuan Yin
    Kathleen Kelly
    [J]. Oncogene, 2019, 38 : 6241 - 6255